Pill Packets

Pharmaceuticals 'not doing enough' to develop new antibiotics

By: Information Daily Staff Writer
Published: Tuesday, November 19, 2013 - 17:04 GMT Jump to Comments

Pharmaceutical companies are not doing enough to develop new antibiotics following an increase in antibiotic-resistant infections worldwide, said Dr Jason Clark, Chief Technology Officer of Novolytics.

Speaking exclusively to the Information Daily at Global Health 2013: Rise of the Resistance, Dr Clark explained how Novolytics aims to exploit the therapeutic potential offered by bacteriophages (“phages”) in a way which is commercially viable and attractive to its investors.

A bacteriophage is a virus that infects bacteria and is seen as a possible future treatment against strains of antibiotic-resistant infections. It is understood that phages kill one quarter of the bacteria on the planet every day.

Dr Clark said: “Bacteriophages are everywhere. They're on your skin, in your food, phages are in your stomach, you probably have more phages in your body than you do bacteria and they're completely inert in humans and other mammals so they're very safe”.

Dr Clark explained precisely how his company is treating antibiotic resistant infections: “At our company we use bacteriophages to treat antibiotic resistant infections, bacteria phages are viruses which only infect bacteria, what they do is infect and kill bacteria such as MRSA and E coli”.

Right now the company are in the stages of research just before Phase 1 clinical trials. All three phases of the clinical trials would take almost ten years to be completed, even though phases 1 and 2 are relatively quick.

“There’s quite a large body of literature suggesting that they are very safe and that they do work, the issue is that they have not been purified in a manner that’s consistent with western regulatory standards.

"They have not been taken through the full clinical trials process and that’s what we are trying to do", said Dr Clark.

Comments

Latest

A new data-driven innovation in caring for patients with Acute Kidney Injury (AKI) will provide real-time preventive…

One focus of the ongoing UK health reforms is improving access to the best healthcare for more people.

Nationally, the NHS must embrace more technology, specifically; self-service technology, and do as much as it…

Over the next 12 months, the new Conservative government will need to make two major decisions which will play…

The Citizens Advice Bureau recently published a report entitled 'Personal data empowerment: time for a fairer…

Tapping into the potential of mobile technology can release healthcare staff from offices and give them the tools…

The whole purpose of clinical trials is to gauge the efficacy and safety of particular treatments. But what about…

We all know how frustrating it is to find that elusive parking space. But it’s not until we quantify our…

Devolution may help rebalance the UK’s growth, but its strategy and execution need to be carefully thought…

In a recent blog post, Dan Slee, director of the communications and PR website Comms2Point0, suggested that open…

Back in 2013, I wrote a piece for The Information Daily about how that year would be the year of digital by default,…

When GP Chair of NHS Cannock Chase CCG, Dr Jonny McMahon, agreed to take part in Reality Bites - The National…